SCHEMBL6637109

SCHEMBL6637109

C[C@H](OCc1c(Cl)cccc1Cl)C(=O)Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKR1B1 P15121 1/20 0.43
▸ ALDH1A1 P00352 7/20 0.41
▸ HPGD P15428 3/20 0.41
▸ POLB P06746 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.40
▸ L3MBTL1 Q9Y468 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ MAPT P10636 1/20 0.38
▸ KMT2A Q03164 4/20 0.37
▸ HTT P42858 1/20 0.37
▸ TAAR1 Q96RJ0 1/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ HTR1A P08908 1/20 0.37
▸ ADRA2A P08913 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ ADRA2B P18089 1/20 0.37
▸ ADRA2C P18825 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6640788 0.81 MMP1 (0.40) ALDH1A1HPGDKDM4EL3MBTL1SMN1; SMN2
SCHEMBL5667835 0.78 SMN1; SMN2 (0.42) AKR1B1ALDH1A1HPGDPOLBKDM4E
SCHEMBL16708451 0.77 SMN1; SMN2 (0.44) AKR1B1ALDH1A1HPGDPOLBKDM4E
SCHEMBL5168366 0.75 ALDH1A1 (0.53) ALDH1A1HPGDL3MBTL1MAPTKMT2A
SCHEMBL839677 0.75 ALDH1A1 (0.53) ALDH1A1HPGDL3MBTL1MAPTKMT2A
SCHEMBL5169494 0.75 ALDH1A1 (0.53) ALDH1A1HPGDL3MBTL1MAPTKMT2A
SCHEMBL7924569 0.75 KMT2A (0.49) ALDH1A1HPGDL3MBTL1KMT2AHTT
SCHEMBL19055337 0.74 SMN1; SMN2 (0.42) AKR1B1ALDH1A1HPGDPOLBKDM4E
SCHEMBL28656889 0.74 ALDH1A1 (0.52) ALDH1A1HPGDL3MBTL1MAPTKMT2A
SCHEMBL19055367 0.73 SMN1; SMN2 (0.41) AKR1B1ALDH1A1HPGDPOLBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1015433-B1 SUBSTITUTED 1,2,3,4,5,6-HEXAHYDRO-2,6-METHANO-3-BENZAZOCINE-10-OLES, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM PHARMA (DE) 2004-05-26 — — EP disclosed
US-6455538-B1 SODIUM CHANNEL MODULATORS; BRAIN AND NERVOUS SYSTEM DISORDERS BOEHRINGER INGELHEIM PHARMA KG (DE) 2002-09-24 — — US disclosed
EP-1015433-A1 SUBSTITUTED 1,2,3,4,5,6-HEXAHYDRO-2,6-METHANO-3-BENZAZOCINE-10-OLES, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS Boehringer Ingelheim Pharma KG (DE) 2000-07-05 — — EP disclosed
WO-1999014199-A1 SUBSTITUTED 1,2,3,4,5,6-HEXAHYDRO-2,6-METHANO-3-BENZAZOCINE-10-OLES, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-03-25 — — WO disclosed
Send feedback